Ensysce Biosciences (ENSC) Director Resigns From Board
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowEnsysce Biosciences (ENSC) announced the resignation of director Curtis Rosebraugh from its board. This departure could result in a shift in corporate governance and strategy. The company did not provide specific reasons for the resignation or any immediate impact on operations. The resignation of a board member can affect investor confidence and market perception of the company’s leadership.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
